119th Congress · House
HRES. 803
Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
committee
Introduced 2025-10-10•Latest 2025-10-10
Origin chamber
House
Cosponsors
11
Latest action
Referred to the House Committee on Energy and Commerce.
Subjects
Key actions
- Submitted in House
- Referred to the House Committee on Energy and Commerce.
Bill text versions
Related bills
No related bills listed.